These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12207104)

  • 1. Atypical antipsychotic drug use and diabetes.
    Ananth J; Venkatesh R; Burgoyne K; Gunatilake S
    Psychother Psychosom; 2002; 71(5):244-54. PubMed ID: 12207104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?
    Ananth J; Kolli S
    Expert Opin Drug Saf; 2005 Jan; 4(1):55-68. PubMed ID: 15709898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents.
    Henderson DC
    J Clin Psychiatry; 2001; 62 Suppl 27():10-4; discussion 40-1. PubMed ID: 11806484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes mellitus and atypical antipsychotics].
    de Sena EP; Sampaio AS; Quarantini Lde C; Oliveira IR
    Braz J Psychiatry; 2003 Oct; 25(4):253-7. PubMed ID: 15328554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia associated with the use of atypical antipsychotics.
    Lindenmayer JP; Nathan AM; Smith RC
    J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S
    Curr Pharm Des; 2004; 10(18):2219-29. PubMed ID: 15281897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.
    Ramaswamy K; Masand PS; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(3):183-94. PubMed ID: 16923657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New onset diabetes and atypical antipsychotics.
    Liebzeit KA; Markowitz JS; Caley CF
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):25-32. PubMed ID: 11226809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes mellitus type II--induced by "atypical" neuroleptics?].
    Wetterling T
    Fortschr Neurol Psychiatr; 2003 Jun; 71(6):312-22. PubMed ID: 12796851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety project.
    Kropp S; Grohmann R; Hauser U; Rüther E; Degner D
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S79-83. PubMed ID: 15052518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.
    Feng S; Melkersson K
    Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.
    Jin H; Meyer JM; Jeste DV
    Ann Clin Psychiatry; 2002 Mar; 14(1):59-64. PubMed ID: 12046641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus development conference on antipsychotic drugs and obesity and diabetes.
    ; ; ;
    Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
    Henderson DC; Cagliero E; Copeland PM; Louie PM; Borba CP; Fan X; Freudenreich O; Goff DC
    J Clin Psychiatry; 2007 Apr; 68(4):533-41. PubMed ID: 17474808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia from olanzapine treatment in adolescents.
    Bloch Y; Vardi O; Mendlovic S; Levkovitz Y; Gothelf D; Ratzoni G
    J Child Adolesc Psychopharmacol; 2003; 13(1):97-102. PubMed ID: 12804130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment.
    Dwyer DS; Bradley RJ; Kablinger AS; Freeman AM
    Ann Clin Psychiatry; 2001 Jun; 13(2):103-13. PubMed ID: 11534925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.